Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.

Saccoccio FM, Jenks JA, Itell HL, Li SH, Berry M, Pollara J, Casper C, Gantt S, Permar SR.

J Infect Dis. 2019 Jul 31;220(5):772-780. doi: 10.1093/infdis/jiz192.

PMID:
31107951
2.

A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.

McVoy MA, Lee R, Saccoccio FM, Hartikka J, Smith LR, Mahajan R, Wang JB, Cui X, Adler SP.

Vaccine. 2015 Dec 16;33(51):7328-7336. doi: 10.1016/j.vaccine.2015.10.078. Epub 2015 Oct 24.

3.

Neutralizing activity of saliva against cytomegalovirus.

Saccoccio FM, Gallagher MK, Adler SP, McVoy MA.

Clin Vaccine Immunol. 2011 Sep;18(9):1536-42. doi: 10.1128/CVI.05128-11. Epub 2011 Jul 27.

4.

Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells.

Saccoccio FM, Sauer AL, Cui X, Armstrong AE, Habib el-SE, Johnson DC, Ryckman BJ, Klingelhutz AJ, Adler SP, McVoy MA.

Vaccine. 2011 Mar 24;29(15):2705-11. doi: 10.1016/j.vaccine.2011.01.079. Epub 2011 Feb 22.

5.

CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections.

Cornberg M, Clute SC, Watkin LB, Saccoccio FM, Kim SK, Naumov YN, Brehm MA, Aslan N, Welsh RM, Selin LK.

J Immunol. 2010 Mar 15;184(6):2825-38. doi: 10.4049/jimmunol.0902168. Epub 2010 Feb 17.

6.

Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.

Cornberg M, Sheridan BS, Saccoccio FM, Brehm MA, Selin LK.

J Virol. 2007 Jan;81(2):934-44. Epub 2006 Nov 1.

Supplemental Content

Loading ...
Support Center